HeraMED Hits Milestones with A$2 M Placement and Quarterly Report: Is the Rebound On?
HeraMED (ASX: HMD) has re-entered the spotlight with two significant announcements: a successful A$2 million placement and the release of…
Airtasker Launches Investor Hub Amid Media Push: Is It Gearing Up for Scale?
When Airtasker (ASX: ART) announced the launch of a new Investor Hub and unveiled a set of fresh media partnerships,…
Great Northern Minerals gets its kicks near Route 66
When Great Northern Minerals (ASX:GNM) announced on 22 August 2025 that it had made a ‘strategic acquisition of a REE-antimony…
Sprintex Revamps: New Deal in Türkiye and Capital Move Fuel Growth Strategy
Sprintex (ASX: SIX) has jolted back into the investor spotlight with two announcements that could reshape its growth trajectory. The…
Emerging Sectors Winning the Attention Economy in The Second Half Of 2025
The attention economy has never been as competitive as it is today, and individuals have an unlimited number of choices…
Top ASX Stock Picks for 2025: 4 Companies on Our Radar
The Traits of High-Quality ASX Stocks — And Our Top ASX Stock Picks for 2025 With close to 2,000 listed…
Why SenSen (ASX: SNS) Shares Fell 23% on Positive Deal News
SenSen Networks: Solid Wins, Tough Market Reaction SenSen Networks (ASX: SNS) opened sharply lower today, even after announcing fresh contract…
Jindalee Lithium (ASX: JLL) Surges 45% on US$500M SPAC Deal for McDermitt
Jindalee Lithium Unlocks US Market Path With SPAC Agreement Jindalee Lithium (ASX: JLL) just delivered one of the most eye-catching…
Telix Pharmaceuticals (ASX:TLX) Gets FDA Green Light to Resubmit — What Investors Should Know
Telix Pharmaceuticals Gains FDA Clarity on Glioma Imaging Agent Telix Pharmaceuticals (ASX: TLX) has given investors reason to sit up…
Brazilian Rare Earths (ASX: BRE): Early Moves in a Global Growth Market
Brazilian Rare Earths (ASX: BRE) – Final Permit Secures Path to Pilot Plant Operations Brazilian Rare Earths (ASX: BRE) has…
Why ClearVue Technologies (ASX: CPV) Just Sparked Fresh Investor Excitement
ClearVue Technologies – Gen3 Solar Vision Glass Breakthrough ClearVue Technologies (ASX: CPV) turned heads this week after its share price…
Artificial Intelligence: Smart Strategies for Investors
How Investors Can Ride the Next Wave of AI Growth NVIDIA (NSDQ: NVDA) has become the face of the artificial…
How Independent is the US Federal Reserve in the Age of Trump?
The US Federal Reserve is under Pressure: Why Gold Is Beating Every Market Gold has always been seen as a…
Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?
Actinogen Medical (ASX:ACW) is the poster child for how volatile biotech stocks can be. the last time we wrote about…
6 ASX stocks facing competitive threats and whether they can prevail
In this article, we’re looking at ASX stocks facing competitive threats – not just standard market competition, but major threats…